A number of factors are known to influence the response to AC chemotherapy, including tumour stage, grade, number of lymph nodes involved, oestrogen receptor (ER), progesterone (PR) and ERBB2 expression (Clarke et al, 2008). This evidence concerns the gene ERBB2 and neoplasm.